Research Article

Isolation, characterization, and docking analysis of endophytic Aspergillus ochraceus NRRL398 metabolites from Eclipta prostrata (L.) L. targeting acetylcholinesterase inhibition

Volume: 13 Number: 2 March 18, 2026
  • Vaishali M. Todkar *
  • Prasanna V. Habbu
  • Venkatrao H. Kulkarni
  • Shrinivas D. Joshi
  • Smita Madagundi
TR EN

Isolation, characterization, and docking analysis of endophytic Aspergillus ochraceus NRRL398 metabolites from Eclipta prostrata (L.) L. targeting acetylcholinesterase inhibition

Abstract

Eclipta prostrata (False Daisy) is widely acknowledged in traditional medicine for its neuroprotective properties, primarily due to its abundant flavonoids and coumestans. However, the chemical and pharmacological potential of its associated endophytic fungi remains underexplored. In this study, we report for the first time the isolation of Aspergillus ochraceus NRRL398 as an endophyte from E. prostrata, and the subsequent isolation and characterization of nine bioactive secondary metabolites from its n-butanol fraction (EPSF-1-NB). Notably, this is the first report of Apigenin and Luteolin being produced by this fungal endophyte, highlighting its unprecedented biosynthetic capability. The isolated compounds comprising two triterpenoids, one phytosterol, two coumestan derivatives, and four flavonoids were structurally elucidated using advanced chromatographic and spectroscopic techniques. In-silico molecular docking against acetylcholinesterase (AChE, PDB ID: 1QTI) using SYBYL-X 2.0 software revealed that Apigenin and Luteolin exhibited the strongest binding affinities with C-scores of 6.93 and 6.88, respectively, outperforming other compounds such as Wedelolactone (5.48), dimethylwedelolactone (5.05), and sterol/triterpenoid constituents. This study provides novel insight into the metabolic versatility of A. ochraceus as an endophyte of E. prostrata, and identifies Apigenin and Luteolin as promising AChE inhibitors of fungal origin. These findings open new avenues for exploring fungal endophytes as untapped sources of neuroprotective agents and warrant further in-vitro and in-vivo validation.

Keywords

Supporting Institution

Soniya education Trust's college of Pharmacy, Dharwad, Karnataka. PhD centre affiliated by Rajiv Gandhi University of Health Sciences,Banglore, Karnataka.

Ethical Statement

NA

Thanks

To the President of the Soniya College of Pharmacy, Dharwad, for providing the required facilities to carry out this study. . special thanks to Dr. Srinivas Joshi for guiding to execute Docking simulations using the Surflex-Dock software.

References

  1. Chaturvedula, V.S.P., & Prakash, I. (2012). Isolation of Stigmasterol and β Sitosterol from the dichloromethane extract of Rubus suavissimus. International Current Pharmaceutical Journal, 1(9), 239-242.
  2. Colletier, J.P., Fournier, D., Greenblatt, H.M., Stojan, J., Sussman, J.L., Zaccai, G., Silman, I., & Weik, M. (2006). Structural insights into substrate traffic and inhibition in acetylcholinesterase. The EMBO Journal, 25(12), 2746-2756. https://doi.org/10.1038/sj.emboj.7601175
  3. Dajas, F. (2012). Life or death: neuroprotective and anticancer effects of quercetin. Journal of Ethnopharmacology, 143(2), 383-396. https://doi.org/10.1016/j.jep.2012.07.005
  4. Fajriah, S., Megawati, M., & Darmawan, A. (2016). Apigenin, an anticancer isolated from Macaranga gigantifolia leaves. Journal of Tropical Life Science, 6(1), 7-9.
  5. Garyali, S., Kumar, A., & Reddy, M.S. (2013). Taxol production by an endophytic fungus, Fusarium redolens, isolated from Himalayan yew. Journal of Microbiology and Biotechnology, 23(10), 1372-1380. https://doi.org/10.4014/jmb.1305.05070
  6. Gasteiger, J., & Marsili, M. (1980). Iterative partial equalization of orbital electronegativity-a rapid access to atomic charges. Tetrahedron, 36(22), 3219-3228. https://doi.org/10.1016/0040-4020(80)80168-2
  7. Hashem, A.H., Saied, E., Amin, B.H., Alotibi, F.O., Al-Askar, A.A., Arishi, A.A., ... & Elbahnasawy, M.A. (2022). Antifungal activity of biosynthesized silver nanoparticles (AgNPs) against aspergilli causing aspergillosis: Ultrastructure Study. Journal of Functional Biomaterials, 13(4), 242. https://doi.org/10.3390/jfb13040242
  8. Joshi, S.D., Dixit, S.R., More, U.A., Raju, K.V.S.N., Narayan, R., Aminabhavi, T.M., & Kulkarni, V.H. (2014). 3D-QSAR and molecular docking studies of 1, 3, 4-oxadiazoles containing substituted phenoxy fragment as inhibitors of enoyl-acyl carrier protein reductase from Escherichia coli. Medicinal Chemistry Research, 23(10), 4542-4558. https://doi.org/10.1007/s00044-014-1013-1

Details

Primary Language

English

Subjects

Plant Biotechnology

Journal Section

Research Article

Early Pub Date

March 18, 2026

Publication Date

March 18, 2026

Submission Date

May 6, 2025

Acceptance Date

February 1, 2026

Published in Issue

Year 2026 Volume: 13 Number: 2

APA
Todkar, V. M., Habbu, P. V., Kulkarni, V. H., Joshi, S. D., & Madagundi, S. (2026). Isolation, characterization, and docking analysis of endophytic Aspergillus ochraceus NRRL398 metabolites from Eclipta prostrata (L.) L. targeting acetylcholinesterase inhibition. International Journal of Secondary Metabolite, 13(2), 452-476. https://doi.org/10.21448/ijsm.1693171
AMA
1.Todkar VM, Habbu PV, Kulkarni VH, Joshi SD, Madagundi S. Isolation, characterization, and docking analysis of endophytic Aspergillus ochraceus NRRL398 metabolites from Eclipta prostrata (L.) L. targeting acetylcholinesterase inhibition. Int. J. Sec. Metabolite. 2026;13(2):452-476. doi:10.21448/ijsm.1693171
Chicago
Todkar, Vaishali M., Prasanna V. Habbu, Venkatrao H. Kulkarni, Shrinivas D. Joshi, and Smita Madagundi. 2026. “Isolation, Characterization, and Docking Analysis of Endophytic Aspergillus Ochraceus NRRL398 Metabolites from Eclipta Prostrata (L.) L. Targeting Acetylcholinesterase Inhibition”. International Journal of Secondary Metabolite 13 (2): 452-76. https://doi.org/10.21448/ijsm.1693171.
EndNote
Todkar VM, Habbu PV, Kulkarni VH, Joshi SD, Madagundi S (June 1, 2026) Isolation, characterization, and docking analysis of endophytic Aspergillus ochraceus NRRL398 metabolites from Eclipta prostrata (L.) L. targeting acetylcholinesterase inhibition. International Journal of Secondary Metabolite 13 2 452–476.
IEEE
[1]V. M. Todkar, P. V. Habbu, V. H. Kulkarni, S. D. Joshi, and S. Madagundi, “Isolation, characterization, and docking analysis of endophytic Aspergillus ochraceus NRRL398 metabolites from Eclipta prostrata (L.) L. targeting acetylcholinesterase inhibition”, Int. J. Sec. Metabolite, vol. 13, no. 2, pp. 452–476, June 2026, doi: 10.21448/ijsm.1693171.
ISNAD
Todkar, Vaishali M. - Habbu, Prasanna V. - Kulkarni, Venkatrao H. - Joshi, Shrinivas D. - Madagundi, Smita. “Isolation, Characterization, and Docking Analysis of Endophytic Aspergillus Ochraceus NRRL398 Metabolites from Eclipta Prostrata (L.) L. Targeting Acetylcholinesterase Inhibition”. International Journal of Secondary Metabolite 13/2 (June 1, 2026): 452-476. https://doi.org/10.21448/ijsm.1693171.
JAMA
1.Todkar VM, Habbu PV, Kulkarni VH, Joshi SD, Madagundi S. Isolation, characterization, and docking analysis of endophytic Aspergillus ochraceus NRRL398 metabolites from Eclipta prostrata (L.) L. targeting acetylcholinesterase inhibition. Int. J. Sec. Metabolite. 2026;13:452–476.
MLA
Todkar, Vaishali M., et al. “Isolation, Characterization, and Docking Analysis of Endophytic Aspergillus Ochraceus NRRL398 Metabolites from Eclipta Prostrata (L.) L. Targeting Acetylcholinesterase Inhibition”. International Journal of Secondary Metabolite, vol. 13, no. 2, June 2026, pp. 452-76, doi:10.21448/ijsm.1693171.
Vancouver
1.Vaishali M. Todkar, Prasanna V. Habbu, Venkatrao H. Kulkarni, Shrinivas D. Joshi, Smita Madagundi. Isolation, characterization, and docking analysis of endophytic Aspergillus ochraceus NRRL398 metabolites from Eclipta prostrata (L.) L. targeting acetylcholinesterase inhibition. Int. J. Sec. Metabolite. 2026 Jun. 1;13(2):452-76. doi:10.21448/ijsm.1693171
International Journal of Secondary Metabolite

e-ISSN: 2148-6905